Pressmeddelande -
Priveq - new growth partner to Swemac
Swemac Innovation AB (“Swemac”), a developer of innovative solutions for fracture treatment and joint replacement with a focus on hips and upper extremities, welcomes Priveq Investment (“Priveq”) as new minority owner to support the company in its accelerated growth strategy. The Hansson family will continue as majority owners in the company.
Swemac was founded in 1985 as a spin-off from Saab Combitech, from which the Hansson family acquired the medical implant division in 1997. Since the foundation, Swemac has grown within a unique and innovative environment, where new products continuously have been developed. Swemac has exhibited strong growth and profitability historically, and by partnering with Priveq the intention is to accelerate growth even further.
Today Swemac has an extensive product portfolio that are protected by several patents. The products are marketed in Scandinavia and Japan as well as numerous international markets. The group currently has approximately 80 employees with its head office in Linköping and a turnover of around SEK 240m.
“We are highly impressed of Swemac’s innovative spirit and commitment to deliver qualitative products that add value to clients and health care professionals. Swemac’s position is a strong foundation for continued expansion and we are looking forward to be working with the owners and management on this journey going forward”, says Senai Ayob, Partner and Investment manager at Priveq.
“Over the years, Swemac has developed into a strong and broad supplier of products and services to the orthopaedic sector. Our product portfolio is highly innovative and with Priveq as a partner, we will be able to accelerate our growth further, both in terms of new product launches but also in terms of entering new markets. The experience and competence found in Priveq appeals to me“, says Martin Sjögren, CEO at Swemac.
For more information, please contact
Senai Ayob, Partner Priveq
+46 70 459 23 61
senai.ayob@priveq.se
Martin Sjögren, CEO Swemac Innovation AB
+46 70 915 16 95
martin.sjogren@swemac.com
About Swemac
We strive continuously to provide the market with innovative and practical solutions for fracture treatment and joint replacement to benefit patients and health care professionals. Swemac has evolved over the years within a highly innovative environment where quality has always been critical to development and production. This strong tradition of innovation and high quality remains a core characteristic and guiding compass for Swemac today. The products are currently sold via Swemac’s own sales organization in Scandinavia and through distributors on international markets. Also 3rd party brands within trauma treatment and medical imaging are distributed by Swemac in Scandinavia. The company is headquartered in Linköping and has ca 80 employees.
Visit www.swemac.com for more information.
Ämnen
Kategorier
Regioner
About Priveq
For more than 35 years, Priveq has invested in profitable growth companies. The business concept is to generate value through long-term investments and active ownership in unlisted growth companies. Since 1983, approximately SEK 8 billion has been managed and Priveq and its employees have carried out 131 investments and been involved in taking 28 companies to an IPO. The current portfolio will after the investment in Swemac consist of 20 companies which have a total revenue of approximately SEK 4 billion and 2,000 employees. Some of the current portfolio companies are CSAM Health, ILT Inläsningstjänst, Omegapoint, and Ports Group. Behind Priveq Investment is essentially a number of long-term, institutional pension funds in the Nordics and Europe, for example Skandia Liv and Fjärde AP-fonden.
Visit www.priveq.se for more information.
